Hem › Endometriecancer › Missouri › St. Louis
Kliniska studier för Endometriecancer i St. Louis, MO
29 studier för Endometriecancer söker deltagare vid platser i och runt St. Louis (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekryterarFas 3
- Washington University School of Medicine, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi bort
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 mi bort
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- och 6 fler
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Washington University Medicine, St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekryterarFas 2
- Washington University, School of Medicine, St Louis
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RekryterarFas 2
- Washington University School of Medicine, St Louis
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RekryterarFas 1
- Research Site, St Louis
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
RekryterarFas 2
- Washington University School of Medicine, St Louis
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekryterarFas 1
- Washington University, St Louis
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekryterarFas 1/2
- Washington Univ. School of Medicine, St Louis
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekryterarFas 1/2
- Research Site, St Louis
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RekryterarFas 3
- Washington University School of Medicine, St Louis
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekryterarFas 3
- Research Site, St Louis
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
RekryterarFas 1
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekryterarFas 1/2
- Washington University School of Medicine, St Louis
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekryterarFas 1
- Washington University, Siteman Cancer Center, St Louis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekryterarFas 1
- Normunity Investigational Site, St Louis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Washington University School of Medicine, St Louis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Washington University, St Louis
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Investigative Site #110, St Louis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekryterarFas 2
- 521, St Louis
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- Washington University, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
RekryterarObservationsstudie
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
A Study of LY4175408 in Participants With Advanced Cancer
RekryterarFas 1
- Washington University, St Louis
Uterine Preservation Via Lifestyle Transformation
RekryterarFas 2
- Washington University School of Medicine, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RekryterarFas 1
- Washington University Medical Campus, St Louis
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
RekryterarFas 1
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, St Louis
Mindfulness in Endometrial and Cervical Cancer
RekryterarFriska volontärer välkomna
- Saint Louis University, St Louis
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RekryterarFas 2/3
- Washington University School of Medicine, St Louis
Endometriecancer-studier i andra städer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
- Queens, NY25 studier
Andra studier i St. Louis
- Icke-småcellig lungcancer73 studier
- Bröstcancer64 studier
- Metastaserande cancer54 studier
- Kolorektal cancer50 studier
- Cancer (alla typer)46 studier
- Prostatacancer46 studier
- Lungcancer39 studier
- Äggstockscancer38 studier
- Bukspottkörtelcancer33 studier
- Plattenepitelcancer i huvud och hals28 studier
- Hjärtsvikt26 studier
- Övervikt25 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.